VELSIPITY has demonstrated safety data in clinical trials
VELSIPITY should not be taken by patients with certain cardiac conditions such as prior heart attack, chest pain, stroke or heart failure. VELSIPITY can cause serious side effects including infections (some life threatening), a slow heart rate known as bradyarrhythmia, liver problems, increased blood pressure, a vision problem called macular edema, certain types of skin cancer, swelling and narrowing of the blood vessels in your brain, or shortness of breath. See full Important Safety Information at the bottom of this page.
The safety of VELSIPITY has been studied in a clinical program with 577 participants taking VELSIPITY across 3 placebo-controlled studies.
Across two 12-week studies, 6% of people taking VELSIPITY discontinued due to side effects. In the 52-week study, 4% of people taking VELSIPITY discontinued due to side effects.
/global/sign-up-banner